ClinicalTrials.Veeva

Menu

Single-center, Randomized, Superiority Pivotal Clinical Study to Evaluate the Efficacy of Artificial Intelligence-based Upper Gastrointestinal Endoscopy Image

C

Chuncheon Sacred Heart Hospital

Status

Completed

Conditions

Artificial Intelligence
Gastric Neoplasm
Gastric Lesion

Study type

Observational

Funder types

Other

Identifiers

NCT06969794
AI RCT2

Details and patient eligibility

About

We will conduct a single-center retrospective study at a university hospital. A total of 3,385 gastroscopic white-light images from patients with pathologically confirmed findings will be analyzed. The AI software will automatically identify images as non-neoplastic or neoplastic (low-grade dysplasia, high-grade dysplasia, early gastric cancer with mucosal or submucosal invasion, or advanced gastric cancer) and highlighted lesion locations. Two experienced endoscopists will independently review the same image set without AI assistance for comparison. Primary outcomes are sensitivity and specificity of the AI in detecting gastric neoplasms (by category and overall), and the localization accuracy measured by the localization receiver operating characteristic (LROC) curve area. Secondary outcomes is includes comparison of the AI's diagnostic performance with that of endoscopists.

Full description

We will conduct a single-center retrospective study at a university hospital. A total of 3,385 gastroscopic white-light images from patients with pathologically confirmed findings will be analyzed. The AI software will automatically identify images as non-neoplastic or neoplastic (low-grade dysplasia, high-grade dysplasia, early gastric cancer with mucosal or submucosal invasion, or advanced gastric cancer) and highlighted lesion locations. Two experienced endoscopists will independently review the same image set without AI assistance for comparison. Primary outcomes are sensitivity and specificity of the AI in detecting gastric neoplasms (by category and overall), and the localization accuracy measured by the localization receiver operating characteristic (LROC) curve area. Secondary outcomes is includes comparison of the AI's diagnostic performance with that of endoscopists.

Inclusion criteria:

Age 19 or older At least one gastric lesion biopsied with a definitive pathological diagnosis Availability of high-quality white-light endoscopy images of the lesion and surrounding mucosa

Exclusion criteria:

Poor-quality images (e.g., out of focus or obscured) Lack of histopathological confirmation of the lesion

Each image will be paired with a reference standard diagnosis based on the pathology result for that lesion or region.

Enrollment

3,385 patients

Sex

All

Ages

20 to 100 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age 19 or older
  • At least one gastric lesion biopsied with a definitive pathological diagnosis
  • Availability of high-quality white-light endoscopy images of the lesion and surrounding mucosa

Exclusion criteria

  • Poor-quality images (e.g., out of focus or obscured)
  • Lack of histopathological confirmation of the lesion

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems